As the detection of other circulating biomarkers can occur earlier than the detection of circulating tumor cells, another team of researchers (Lan et al.)focused on developing an assay for the quantitative detection of vascular endothelial growth factor (VEGF), a circulating protein that has an increased concentration in breast cancer patients [54]. The gene discussed is VEGFA; the disease is breast cancer.